Zhitong Finance App News, Borui Pharmaceutical (688166.SH) issued an announcement. Recently, Atmy (Suzhou) Pharmaceutical Technology Co., Ltd., a holding subsidiary of the company, received the “tiotropium bromide inhalation spray” and “Drug Registration Certificate” issued by the State Drug Administration. Tiotropium bromide inhalation spray is suitable for the maintenance and treatment of chronic obstructive pulmonary disease (COPD, COPD, including chronic bronchitis and emphysema) and related breathing difficulties, improving the quality of life of COPD patients and reducing acute exacerbation of COPD.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.